IT202200007754A1 - Nuovi composti con attivita’ farmacologica - Google Patents

Nuovi composti con attivita’ farmacologica Download PDF

Info

Publication number
IT202200007754A1
IT202200007754A1 IT102022000007754A IT202200007754A IT202200007754A1 IT 202200007754 A1 IT202200007754 A1 IT 202200007754A1 IT 102022000007754 A IT102022000007754 A IT 102022000007754A IT 202200007754 A IT202200007754 A IT 202200007754A IT 202200007754 A1 IT202200007754 A1 IT 202200007754A1
Authority
IT
Italy
Prior art keywords
new compounds
pharmacological activity
pharmacological
activity
compounds
Prior art date
Application number
IT102022000007754A
Other languages
English (en)
Inventor
Vincenzo Pavone
Daniele D'alonzo
Fenza Maria De
Original Assignee
Iridea S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iridea S R L filed Critical Iridea S R L
Priority to IT102022000007754A priority Critical patent/IT202200007754A1/it
Priority to PCT/IB2023/053941 priority patent/WO2023203473A1/en
Publication of IT202200007754A1 publication Critical patent/IT202200007754A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/42—Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT102022000007754A 2022-04-19 2022-04-19 Nuovi composti con attivita’ farmacologica IT202200007754A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102022000007754A IT202200007754A1 (it) 2022-04-19 2022-04-19 Nuovi composti con attivita’ farmacologica
PCT/IB2023/053941 WO2023203473A1 (en) 2022-04-19 2023-04-18 Arylthio derivatives with pharmacological activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000007754A IT202200007754A1 (it) 2022-04-19 2022-04-19 Nuovi composti con attivita’ farmacologica

Publications (1)

Publication Number Publication Date
IT202200007754A1 true IT202200007754A1 (it) 2023-10-19

Family

ID=82482917

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000007754A IT202200007754A1 (it) 2022-04-19 2022-04-19 Nuovi composti con attivita’ farmacologica

Country Status (2)

Country Link
IT (1) IT202200007754A1 (it)
WO (1) WO2023203473A1 (it)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277818B1 (en) 1998-10-29 2001-08-21 Angstrom Pharmaceuticals, Inc. Cyclic peptide ligands that target urokinase plasminogen activator receptor
WO2002069885A2 (en) 2001-01-19 2002-09-12 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases
WO2003048127A1 (en) * 2001-12-04 2003-06-12 Corvas International, Inc. Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
US20040266766A1 (en) 2001-12-12 2004-12-30 Wilex Ag Selective urokinase inhibitors
WO2008017372A1 (en) 2006-08-09 2008-02-14 Maria Vincenza Carriero Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
WO2010102253A2 (en) 2009-03-06 2010-09-10 Angstrom Pharmaceuticals, Inc. Compositions and methods for modulation of cell migration
WO2017121766A1 (en) 2016-01-12 2017-07-20 Kaleyde Pharmaceuticals Ag Pharmaceutical formulations and their use for the treatment of retinitis pigmentosa
WO2017121764A1 (en) 2016-01-12 2017-07-20 Kaleyde Pharmaceuticals Ag Pharmaceutical formulations for the treatment of diabetes
WO2017178333A1 (en) 2016-04-11 2017-10-19 Istituto Nazionale Tumori Irccs - "Fondazione G. Pascale" Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277818B1 (en) 1998-10-29 2001-08-21 Angstrom Pharmaceuticals, Inc. Cyclic peptide ligands that target urokinase plasminogen activator receptor
WO2002069885A2 (en) 2001-01-19 2002-09-12 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases
WO2003048127A1 (en) * 2001-12-04 2003-06-12 Corvas International, Inc. Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
US20040266766A1 (en) 2001-12-12 2004-12-30 Wilex Ag Selective urokinase inhibitors
WO2008017372A1 (en) 2006-08-09 2008-02-14 Maria Vincenza Carriero Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
WO2010102253A2 (en) 2009-03-06 2010-09-10 Angstrom Pharmaceuticals, Inc. Compositions and methods for modulation of cell migration
WO2017121766A1 (en) 2016-01-12 2017-07-20 Kaleyde Pharmaceuticals Ag Pharmaceutical formulations and their use for the treatment of retinitis pigmentosa
WO2017121764A1 (en) 2016-01-12 2017-07-20 Kaleyde Pharmaceuticals Ag Pharmaceutical formulations for the treatment of diabetes
WO2017178333A1 (en) 2016-04-11 2017-10-19 Istituto Nazionale Tumori Irccs - "Fondazione G. Pascale" Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells

Non-Patent Citations (61)

* Cited by examiner, † Cited by third party
Title
BAYES HKRITCHIE NIRVINE SEVANS TJ: "A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection", SKI REP, vol. 6, 2 November 2016 (2016-11-02), pages 35838
BOCCELLA, S. ET AL., INFLAMM. RES., vol. 66, 2017, pages 701 - 709
CAMMALLERI, M. ET AL., CELLS, vol. 8, 2019, pages 925
CAMMALLERI, M. ET AL., INVEST. OPHTHALMOL. VIEW SKIING., vol. 57, 2016, pages 5723 - 5735
CAMMALLERI, M. ET AL., INVEST. OPHTHALMOL. VIEW SKIING., vol. 58, 2017, pages 3138 - 3148
CAMMALLERI, M. ET AL., J. CELL. MOL. MED., vol. 23, 2019, pages 5176 - 5192
CAMMALLERI, M. ET AL., J. DIABETES RES., 2017, pages 18
CARRIERO, M.V. ET AL., MOL. CANCER THER., vol. 13, 2014, pages 1092 - 1104
CASTELLANO, G. ET AL., J. ALLERGY CLIN. IMMUNOL., vol. 142, 2018, pages 883 - 891
CHALKIAS, A. ET AL., MOL. DIAGN. THER., vol. 24, 2020, pages 517 - 521
CHEN D ET AL., EXP THER MEAN, vol. 18, 2019, pages 2984 - 2992
DAVIS, J. ET AL., J. BIOL. CHEM., vol. 278, 2003, pages 19054 - 19061
DEGRABA, T. ET AL., CANCEL NEUROL, vol. 47, 2001, pages 229 - 233
DINESH, P. ET AL., PHARMACOL. RES., vol. 134, 2018, pages 31 - 39
DURAN, C.L. ET AL., COMP. PHYSIOL., vol. 8, 2017, pages 153 - 235
ENOCHSSON H ET AL., J AUTOIMMUN, vol. 106, 2020, pages 102340
EUGEN-OLSEN J ET AL., EUR J CLIN INVEST, vol. 46, 2016, pages 305 - 311
FARRIS, S.D. ET AL., J. BIOL. CHEM., vol. 286, 2011, pages 22665 - 22677
FRARY CE ET AL., EUR J PREV CARDIOL, vol. 27, 2019, pages 570 - 578
GARNAES E ET AL., PLOS ONE, vol. 14, 2019, pages e0220697
GENUA, M. ET AL., INFLAMM. BOWEL DIS., vol. 22, 2016, pages 2390 - 2401
GUMUS A ET AL., INT J CHRON OBSTRUCT PULMON DIS, vol. 10, 2015, pages 357 - 365
GUSSEN H ET AL., J INTENSIVE CARE, vol. 7, 2019, pages 26
GUTHOFF M ET AL., SCI REP, vol. 7, 2017, pages 40627
HAKANSSON KEJ ET AL., RESPIR RES, vol. 20, 2019, pages 258
HALL, A. ET AL., BMC NEPHROLOGY, vol. 19, 2018, pages 191
HOENIGL M ET AL., CLIN BIOCHEM, vol. 46, 2013, pages 225 - 229
HUANG, J.M. ET AL., FRONT. PHARMACOL., vol. 9, 2018, pages 1016
HUANG, W. ET AL., ONCOTARGET, vol. 8, 2017, pages 66951 - 66959
INGANGI, V. ET AL., ONCOTARGET, vol. 7, 2016, pages 54474 - 54487
JOHNSON S ET AL., INT J RADIAT BIOL, 2020, pages 1 - 9
K. BOWDEN ET. AL.: "Multifunctional Derivatives of Metzronidazole", IL FARMACO, vol. 53, 1 January 1999 (1999-01-01), pages 58 - 61, XP002807933, DOI: 10.1016/S0014-827X(97)00007-4 *
K. ROBINSON ET. AL.: "Exploiting Peptidomimetics to synthesize Compounds That Activate Ryanodine Receptor Calcium Release Channels", CHEMMEDCHEM, vol. 13, 29 July 2018 (2018-07-29), pages 1957 - 1971, XP002807932, DOI: 10.1002/cmdc.201800366 *
KOVACS, K. ET AL., INVEST. OPHTHALMOL. VIEW SKIING., vol. 56, 2015, pages 6523 - 6530
LAFER-MACKO, C.E. ET AL., NEUROLOGY, vol. 69, 2007, pages 268 - 274
LOCRI, F. ET AL., J. MOL. MED., vol. 1-11, 2019, pages 1273 - 1283
LOONEN AJM ET AL., EUR J CLIN MICROBIOL INFECT DIS, vol. 36, 2017, pages 1541 - 1547
MADUNIC, J., THROMB. HAEMOST., vol. 118, 2018, pages 2020 - 2036
MT., M. ET AL., J. CELL. MOL. MED., vol. 1-16, 2018, pages 1034 - 1049
NAPOLITANO, F. ET AL., FRONT. IMMUNOL., vol. 9, 2018, pages 574
OKULU E ET AL., J CLIN LAB ANAL, vol. 29, 2015, pages 347 - 352
PAN, H. ET AL., EXP. THER. MED., vol. 15, 2018, pages 5517 - 5522
PAUEKSAKON, P. ET AL., KIDNEY INT, vol. 61, 2002, pages 2142 - 2148
R.M. SARHAN ET. AL.: "Efficient Routes for the Synthesis of Novel Bis(s-triazolo[3,4-b]1,3,4]thiadiazines.", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 51, 1 August 2014 (2014-08-01), pages E176 - E182, XP002807934, DOI: 10.1002/jhet.1854 *
REULAND, C.J. ET AL., MED. HYPOTHESES, vol. 138, 2020, pages 109602
REZZOLA, S. ET AL., DIABETES, vol. 60, 2017, pages 719 - 728
ROSETTI, F. ET AL., IMMUNOL. REV., vol. 269, 2016, pages 175 - 193
RUBINA, K.A. ET AL., ARCH. DERMATOL. RES., vol. 309, 2017, pages 433 - 442
S. KONDO ET. AL.: "Selective recognition of dihydrogen phosphate by receptors bearing pyridyl moieties as hydrogen bond acceptors", CHEMICAL COMMUNICATIONS, vol. 13, 2 February 2005 (2005-02-02), pages 1720 - 1722, XP002807931, DOI: 10.1039/B417304J *
SADICK, H. ET AL., HAEMATOLOGY, vol. 90, 2005, pages 818 - 828
SCHULIGA, M. ET AL., INT. J. BIOCHEM. CELL. BIOL., vol. 97, 2018, pages 108 - 117
SHETTY, S. ET AL., AM. J. PHYSIOL. LUNG CELL. MOL. PHYSIOL., vol. 295, 2007, pages L967 - 7
TEW G.N. ET AL.: "Process born", CAD. SKIING. U.S., vol. 99, 2002, pages 5110 - 5114
THEILADE S ET AL., J INTERN MED, vol. 277, 2015, pages 362 - 371
TSAI PK ET AL., INT J ENVIRON RES PUBLIC HEALTH, vol. 16, 2019, pages 1035
VAN OORT PM ET AL., ERJ OPEN RES, vol. 5, 2019, pages 00212 - 2018
WALKER, D.G. ET AL., BRAIN RES., vol. 926, 2002, pages 69 - 79
WROTEK A ET AL., RESPIR PHYSIOL NEUROBIOL, vol. 209, 2015, pages 120 - 123
WU CZ ET AL., CLIN BIOCHEM, vol. 48, 2015, pages 1324 - 1349
ZHANG Q ET AL., J CLIN LAB ANAL, vol. 34, 2020, pages e23097
ZHAO, Y. ET AL., PLOS ONE, vol. 10, 2015, pages e0132869

Also Published As

Publication number Publication date
WO2023203473A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
IT202200007754A1 (it) Nuovi composti con attivita’ farmacologica
ES1304425Y (es) Cartucho con termo-control
JP1756304S (ja) リアクトル
FIC20240001I1 (fi) Tislelitsumabi
JP1733861S (ja) 建築用金物
JP1718929S (ja) 建築用金物
JP1761884S (ja) ストップウォッチ
JP1765370S (ja) だるま
JP1752037S (ja) 耳かき
JP1747840S (ja) ポシェット
JP1753707S (ja) 散蓮華
JP1741082S (ja) 根付け
JP1738544S (ja) もなか
IT202200007034A1 (it) Composti benzoeterodiazolici disostituiti con gruppi ditienopirrolici.
NO2023039I1 (no) Glofitamab
NO2023037I1 (no) Mirikizumab
CR20230357S (es) Confiteriaconfectionery
CR20230247S (es) Motorcyclemotorcycle
NO2023016I1 (no) nirsevimab
CR20220428S (es) TapónCap
ECSDI22002362S (es) Cordofono
ECSDI22002354S (es) Eléctrofono
JP1744167S (ja) キャビネット付き大便器
TH2302000949S (th) หน้าตัด
TH2202003865S (th) หน้าตัด